Looks like our new COO is in the states learning the ropes this week.
It won't surprise me at all if we get word of the initiation of CHM 2101 any day now. On the clinical trial website, the trials original estimated start date was May. That was changed early this year to mid year. No coincidence it aligns with Jens departure.
From LinkedIn.5dCongratulations and welcome Rebecca!Like1 Reply1 Comment on Eliot Bourk’s comment4dEliot Bourk thank you! Can’t wait to meet you in person next week!
- Forums
- ASX - By Stock
- Ann: Dr Rebecca McQualter appointed COO
Looks like our new COO is in the states learning the ropes this...
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.4¢ | $15.87K | 1.103M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1876837 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 96056 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1876837 | 0.014 |
13 | 2770922 | 0.013 |
5 | 1066816 | 0.012 |
4 | 697817 | 0.011 |
5 | 485143 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 96056 | 2 |
0.016 | 735854 | 3 |
0.017 | 647827 | 3 |
0.018 | 1788235 | 5 |
0.019 | 987804 | 3 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
Eliot BourkView Eliot Bourk’s profile• 3rd+Chief Business Officer at Chimeric Therapeutics